** Shares of medical device maker Neuropace NPCE.O fall 16.54% to $10.09
** Co announces the pricing of $65 million of common stock
** Co plans to offers 6.5 million shares at a public offering price of $10.00 per share; 17.3% discount to last closing price
** Grants underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock at the public offering price
** The offering is expected to close on February 18
** Co has 29.85 mln shares outstanding, giving it a ~360 mln market cap - data compiled from LSEG
** The stock has fallen ~27% in the last 12 months
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。